Security key
416906105
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 4,518,092
- Total 13F shares
- 26,562,238
- Share change
- +5,971,439
- Total reported value
- $82,344,380
- Price per share
- $3.10
- Number of holders
- 85
- Value change
- +$19,093,143
- Number of buys
- 61
- Number of sells
- 17
Report period
Q2 2020
Institutions
85
Top holders
10
HBIO full security history
Newer quarter: Q3 2020
Previous quarter: Q1 2020
HARVARD BIOSCIENCE INC SEC filings
HARVARD BIOSCIENCE INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 416906105
Recent filing periods:
Top shareholders of HBIO - HARVARD BIOSCIENCE INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Engine Capital Management, LP |
13F
|
Company |
85%
|
3,828,907
|
$10,768,000 | — | 31 Mar 2020 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
48%
|
2,157,966
|
$4,769,000 | — | 31 Mar 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
44%
|
2,002,703
|
$4,426,000 | — | 31 Mar 2020 | |
| Granahan Investment Management, LLC |
13F
|
Company |
41%
|
1,846,148
|
$4,080,000 | — | 31 Mar 2020 | |
| Harvey Partners, LLC |
13F
|
Company |
38%
|
1,708,466
|
$3,776,000 | — | 31 Mar 2020 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
37%
|
1,681,000
|
$3,715,000 | — | 31 Mar 2020 | |
| DALTON GREINER HARTMAN MAHER & CO |
13F
|
Company |
36%
|
1,619,393
|
$3,579,000 | — | 31 Mar 2020 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
26%
|
1,169,948
|
$2,586,000 | — | 31 Mar 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
24%
|
1,105,921
|
$2,444,000 | — | 31 Mar 2020 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
24%
|
1,071,962
|
$2,372,000 | — | 31 Mar 2020 | |
| HEARTLAND ADVISORS INC |
13F
|
Company |
22%
|
1,000,000
|
$2,210,000 | — | 31 Mar 2020 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
15%
|
676,830
|
$1,496,000 | — | 31 Mar 2020 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
14%
|
626,217
|
$1,384,000 | — | 31 Mar 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
12%
|
535,226
|
$1,183,000 | — | 31 Mar 2020 | |
| Invenomic Capital Management LP |
13F
|
Company |
11%
|
491,562
|
$1,086,000 | — | 31 Mar 2020 | |
| BARD ASSOCIATES INC |
13F
|
Company |
6.9%
|
312,772
|
$691,000 | — | 31 Mar 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
6.1%
|
273,499
|
$604,000 | — | 31 Mar 2020 | |
| ESSEX INVESTMENT MANAGEMENT CO LLC |
13F
|
Company |
5.5%
|
250,000
|
$553,000 | — | 31 Mar 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
3.5%
|
158,792
|
$350,000 | — | 31 Mar 2020 | |
| ClariVest Asset Management LLC |
13F
|
Company |
3.4%
|
154,392
|
$341,000 | — | 31 Mar 2020 | |
| WEDGE CAPITAL MANAGEMENT L L P/NC |
13F
|
Company |
3.4%
|
151,792
|
$335,000 | — | 31 Mar 2020 | |
| OXFORD ASSET MANAGEMENT LLP |
13F
|
Company |
2.8%
|
127,175
|
$281,000 | — | 31 Mar 2020 | |
| Adirondack Research & Management Inc. |
13F
|
Company |
2.8%
|
126,242
|
$279,000 | — | 31 Mar 2020 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
2.7%
|
123,240
|
$272,000 | — | 31 Mar 2020 | |
| J.P. Morgan Private Wealth Advisors LLC |
13F
|
Company |
2.6%
|
115,243
|
$255,000 | — | 31 Mar 2020 | |
| GREENWOOD CAPITAL ASSOCIATES LLC |
13F
|
Company |
2.4%
|
108,529
|
$240,000 | — | 31 Mar 2020 | |
| GLOBEFLEX CAPITAL L P |
13F
|
Company |
2.3%
|
103,231
|
$228,000 | — | 31 Mar 2020 | |
| Fondren Management LP |
13F
|
Company |
2.2%
|
100,000
|
$221,000 | — | 31 Mar 2020 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
2%
|
89,356
|
$197,000 | — | 31 Mar 2020 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
1.6%
|
72,482
|
$160,000 | — | 31 Mar 2020 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
1.6%
|
70,115
|
$155,000 | — | 31 Mar 2020 | |
| SEIZERT CAPITAL PARTNERS, LLC |
13F
|
Company |
1.3%
|
58,693
|
$130,000 | — | 31 Mar 2020 | |
| Invesco Ltd. |
13F
|
Company |
1.3%
|
56,999
|
$126,000 | — | 31 Mar 2020 | |
| HighMark Wealth Management LLC |
13F
|
Company |
1.1%
|
50,985
|
$112,000 | — | 31 Mar 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
1.1%
|
50,480
|
$111,000 | — | 31 Mar 2020 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
1%
|
45,775
|
$101,000 | — | 31 Mar 2020 | |
| WINTON GROUP Ltd |
13F
|
Company |
0.96%
|
43,475
|
$96,000 | — | 31 Mar 2020 | |
| Alambic Investment Management, L.P. |
13F
|
Company |
0.85%
|
38,359
|
$85,000 | — | 31 Mar 2020 | |
| Pasadena Private Wealth, LLC |
13F
|
Company |
0.79%
|
35,725
|
$83,000 | — | 31 Mar 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.79%
|
35,877
|
$79,000 | — | 31 Mar 2020 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.49%
|
21,949
|
$49,000 | — | 31 Mar 2020 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.47%
|
21,300
|
$47,000 | — | 31 Mar 2020 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.43%
|
19,497
|
$43,000 | — | 31 Mar 2020 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0.36%
|
16,138
|
$36,088 | — | 31 Mar 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.31%
|
14,026
|
$31,000 | — | 31 Mar 2020 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.3%
|
13,357
|
$28,000 | — | 31 Mar 2020 | |
| WHITE PINE CAPITAL LLC |
13F
|
Company |
0.28%
|
12,700
|
$28,000 | — | 31 Mar 2020 | |
| Zebra Capital Management LLC |
13F
|
Company |
0.27%
|
12,334
|
$27,000 | — | 31 Mar 2020 | |
| STATE STREET CORP |
13F
|
Company |
0.25%
|
11,459
|
$25,000 | — | 31 Mar 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.24%
|
11,028
|
$24,000 | — | 31 Mar 2020 |
Institutional Holders of HARVARD BIOSCIENCE INC - Common Stock (HBIO) as of Q2 2020
As of 30 Jun 2020,
HARVARD BIOSCIENCE INC - Common Stock (HBIO) was held by
85 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,562,238 shares.
The largest 10 holders included
BlackRock Inc., DIMENSIONAL FUND ADVISORS LP, VANGUARD GROUP INC, ROYCE & ASSOCIATES LP, GRANAHAN INVESTMENT MANAGEMENT INC/MA, DALTON GREINER HARTMAN MAHER & CO, KENNEDY CAPITAL MANAGEMENT, INC., ACADIAN ASSET MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, and PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC..
This page lists
85
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2020 vs Q1 2020 Across Filers
Q1 2020 holders
57
Q2 2020 holders
85
Holder diff
28
| Investor | Q1 2020 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q1 2020 Value $ | Q2 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.